您的位置: 首页 > 农业专利 > 详情页

INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE
专利权人:
INC.;HARM REDUCTION THERAPEUTICS
发明人:
John STRANG,Alexander OKSCHE,Stephen HARRIS,Kevin SMITH,Lucie Helene Jeanne MOTTIER
申请号:
US16549838
公开号:
US20190374464A1
申请日:
2019.08.23
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ≥;0.5 mg naloxone HC dissolved in an application fluid of a volume of ≤;250 μl. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充